Carola Schröder

Title: Carola Schröder: Innovator in Recombinant Protein Technologies

Introduction

Carola Schröder is a prominent inventor based in Neuried, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant proteins. With a total of 3 patents to her name, her work has had a substantial impact on medical science.

Latest Patents

Among her latest patents, Carola has developed a recombinant human factor VIII and IX protein. This innovative protein possesses a human glycosylation pattern while being devoid of N-glycolylneuraminic acid and/or the carbohydrate group Galα-3Gal. Additionally, she has worked on the processing of recombinant human G-CSF precursor, which includes a signal peptide and a G-CSF peptide. The signal peptide features the sequence of the human wild-type signal peptide of the human G-CSF/b molecule, incorporating at least one mutation.

Career Highlights

Throughout her career, Carola has been associated with notable companies such as Octapharma AG and Octagene GmbH. Her work in these organizations has allowed her to advance her research and contribute to the development of critical biopharmaceuticals.

Collaborations

Carola has collaborated with esteemed colleagues, including Michael Lehnerer and Elisabeth Casademunt. These partnerships have fostered innovation and have been instrumental in her research endeavors.

Conclusion

Carola Schröder's contributions to recombinant protein technologies exemplify her dedication to advancing medical science. Her innovative patents and collaborations highlight her role as a leading inventor in the biotechnology field.